Home/Filings/4/0001140361-10-011343
4//SEC Filing

Keese Kyle 4

Accession 0001140361-10-011343

CIK 0001367644other

Filed

Mar 10, 7:00 PM ET

Accepted

Mar 11, 3:22 PM ET

Size

7.7 KB

Accession

0001140361-10-011343

Insider Transaction Report

Form 4
Period: 2010-03-09
Keese Kyle
SVP, Mfg Ops
Transactions
  • Award

    Common Stock

    2010-03-09+8,7349,070 total
  • Award

    Employee Stock Option (right to buy(

    2010-03-09+17,46917,469 total
    Exercise: $15.91Exp: 2017-03-10Common Stock (17,469 underlying)
Footnotes (3)
  • [F1]Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
  • [F2]These restricted stock units vest in three equal annual installments beginning on the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
  • [F3]Exercisable in three equal installments on March 9, 2011, March 9, 2012 and March 9, 2013.

Documents

1 file

Issuer

Emergent BioSolutions Inc.

CIK 0001367644

Entity typeother

Related Parties

1
  • filerCIK 0001380186

Filing Metadata

Form type
4
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 3:22 PM ET
Size
7.7 KB